IL144874A0 - Thiophene-ethyl thiourea compounds and use in the treatment of hiv - Google Patents
Thiophene-ethyl thiourea compounds and use in the treatment of hivInfo
- Publication number
- IL144874A0 IL144874A0 IL14487400A IL14487400A IL144874A0 IL 144874 A0 IL144874 A0 IL 144874A0 IL 14487400 A IL14487400 A IL 14487400A IL 14487400 A IL14487400 A IL 14487400A IL 144874 A0 IL144874 A0 IL 144874A0
- Authority
- IL
- Israel
- Prior art keywords
- hiv
- treatment
- thiophene
- thiourea compounds
- ethyl thiourea
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/338,685 US6124324A (en) | 1999-06-23 | 1999-06-23 | Thiophene-ethyl thiourea compounds and use |
| PCT/US2000/017361 WO2000078755A1 (en) | 1999-06-23 | 2000-06-23 | Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL144874A0 true IL144874A0 (en) | 2002-06-30 |
Family
ID=23325726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14487400A IL144874A0 (en) | 1999-06-23 | 2000-06-23 | Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6124324A (xx) |
| EP (1) | EP1194427B1 (xx) |
| JP (1) | JP2003502423A (xx) |
| KR (1) | KR20020012287A (xx) |
| CN (1) | CN1196697C (xx) |
| AT (1) | ATE233758T1 (xx) |
| AU (2) | AU6539900A (xx) |
| BR (1) | BR0009102A (xx) |
| CA (1) | CA2375261A1 (xx) |
| DE (1) | DE60001581T2 (xx) |
| ES (1) | ES2195905T3 (xx) |
| IL (1) | IL144874A0 (xx) |
| MX (1) | MXPA01009283A (xx) |
| WO (2) | WO2000078756A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001219672A1 (en) * | 2000-10-18 | 2002-04-29 | Parker Hughes Institute | Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections |
| SE0100733D0 (sv) | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| SE0102867D0 (sv) | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686428A (en) * | 1989-04-07 | 1997-11-11 | Aktiebolaget Astra | Pharmaceutical composition |
| IL102548A (en) * | 1991-08-02 | 1998-08-16 | Medivir Ab | Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds |
| US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
-
1999
- 1999-06-23 US US09/338,685 patent/US6124324A/en not_active Expired - Fee Related
-
2000
- 2000-06-15 WO PCT/US2000/040203 patent/WO2000078756A1/en active Application Filing
- 2000-06-15 AU AU65399/00A patent/AU6539900A/en not_active Abandoned
- 2000-06-23 KR KR1020017016434A patent/KR20020012287A/ko not_active Application Discontinuation
- 2000-06-23 CN CNB008091129A patent/CN1196697C/zh not_active Expired - Fee Related
- 2000-06-23 BR BR0009102-2A patent/BR0009102A/pt not_active Application Discontinuation
- 2000-06-23 AU AU56358/00A patent/AU5635800A/en not_active Abandoned
- 2000-06-23 JP JP2001504921A patent/JP2003502423A/ja not_active Withdrawn
- 2000-06-23 AT AT00941686T patent/ATE233758T1/de not_active IP Right Cessation
- 2000-06-23 DE DE60001581T patent/DE60001581T2/de not_active Expired - Fee Related
- 2000-06-23 CA CA002375261A patent/CA2375261A1/en not_active Abandoned
- 2000-06-23 EP EP00941686A patent/EP1194427B1/en not_active Expired - Lifetime
- 2000-06-23 IL IL14487400A patent/IL144874A0/xx unknown
- 2000-06-23 WO PCT/US2000/017361 patent/WO2000078755A1/en not_active Application Discontinuation
- 2000-06-23 ES ES00941686T patent/ES2195905T3/es not_active Expired - Lifetime
- 2000-06-23 MX MXPA01009283A patent/MXPA01009283A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5635800A (en) | 2001-01-09 |
| MXPA01009283A (es) | 2002-04-10 |
| WO2000078755A1 (en) | 2000-12-28 |
| EP1194427A1 (en) | 2002-04-10 |
| ES2195905T3 (es) | 2003-12-16 |
| DE60001581D1 (de) | 2003-04-10 |
| AU6539900A (en) | 2001-01-09 |
| WO2000078756A1 (en) | 2000-12-28 |
| DE60001581T2 (de) | 2004-02-19 |
| JP2003502423A (ja) | 2003-01-21 |
| ATE233758T1 (de) | 2003-03-15 |
| CN1356997A (zh) | 2002-07-03 |
| CA2375261A1 (en) | 2000-12-28 |
| EP1194427B1 (en) | 2003-03-05 |
| KR20020012287A (ko) | 2002-02-15 |
| BR0009102A (pt) | 2002-01-08 |
| CN1196697C (zh) | 2005-04-13 |
| US6124324A (en) | 2000-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| MX2007002236A (es) | S-triazolil-alfa-mercaptoacetanilidas como inhibidores de transcriptasa inversa de virus de inmunodeficiencia humana. | |
| MY142948A (en) | Benzophenones as inhibitors of reverse transcriptase | |
| RS50091B (sr) | Upotreba retigabina u lečenju neuropatskog bola | |
| AU2003291998A8 (en) | Method and compositions for identifying anti-hiv therapeutic compounds | |
| IL144294A0 (en) | P53 inhibitors and therapeutic use of the same | |
| ATE175608T1 (de) | Vollbohrer | |
| MXPA05010706A (es) | Uso de un inhibidor del transporte de acido biliar ileal (ibat) para el tratamiento o profilaxis del estrenimiento. | |
| AU5414000A (en) | Compounds | |
| HK1026691A1 (en) | Substituted benzimidazoles and their use for treating retroviral infection | |
| TR200103216T2 (tr) | Pirimidinon bileşimleri | |
| SI1372650T1 (sl) | Kombinacije, ki obsegajo antidiaroično sredstvo in epotilon ali epotilonski derivat | |
| LU91433I2 (fr) | "Tenofovir disoproxil et les sels, en particulier le fumarate, hydrates, tautomers et solvates en combination avec l'emtricitabine et l'efavirenz (ATRIPLA) | |
| WO2006034001A3 (en) | Methods of treating hiv infection | |
| TR200502508T2 (tr) | IL-18 İnhibitörlerinin kullanımı. | |
| ATE312079T1 (de) | Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion | |
| NO993670L (no) | Quinoksalin i trippelkombinasjon med proteaseinhibitorer og reverse transkriptaseinhibitorer som medikamenter for behandling av AIDS | |
| MXPA02009705A (es) | Nueva combinacion de un betabloqueador y un agente de disminucion de colesterol. | |
| IL144874A0 (en) | Thiophene-ethyl thiourea compounds and use in the treatment of hiv | |
| TR200302134T4 (tr) | 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. | |
| MX9705916A (es) | Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc. | |
| WO2003100036A3 (fr) | Sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih. | |
| TR200002939T2 (tr) | Paroksetin maleat | |
| MX9704024A (es) | Composicion y metodo para la prevencion y el tratamiento de infeccion con vih-1. |